ALK-Abelló
CPSE:ALK B Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 26 Fair Values set on narratives written by author
WA
Consensus Narrative from 4 Analysts
Allergy+ Strategy And Neffy Nasal Spray Will Ignite Revenue Growth And Boost Earnings
Key Takeaways The Allergy+ strategy and neffy nasal spray deal are expected to create new revenue streams and drive growth from 2025 onward. Continuous international growth in tablet sales and cost-saving measures indicate sustained revenue growth and improved operational efficiency.
View narrativeDKK 179.20
FV
11.8% undervalued intrinsic discount11.50%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
24 days ago author updated this narrative